Both in Pharmaceuticals
RenovoRx vs Gossamer Bio
Over the past year RNXT returned +33.1% and GOSS returned −94.9%; their daily moves had a correlation of -0.06.
RNXT +33.1% GOSS −94.9%Growth of $1, one year, split-adjusted
| Metric | RNXT | GOSS |
|---|---|---|
| Price | $1.57 | $11.58 |
| Market cap | $70.9M | $70.8M |
| Today | +1.29% | +0.52% |
| 1 month | −6.0% | −14.9% |
| 6 months | +46.7% | −54.8% |
| Year to date | +86.9% | −95.3% |
| 1 year | +33.1% | −94.6% |
| Revenue growth (YoY) | +115.4% | −19.6% |
| Gross margin | 84.3% | 100.0% |
| Net margin | −320.2% | 182.9% |
| P/E (TTM) | — | — |
| Price / sales | 35.9× | 1.3× |
| Net cash | $9.5M | $20.9M |
| Dividend yield | — | — |
| Volatility (60d) | 107.0% | 1,269.6% |
| Short % of float | 1.6% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).